It has been reported that heme can inhibit cell death via HO-1 and caspase-3 mediation, and HO-1 induction can be used to treat glucocorticoid-related osteonecrosis and osteoporosis [39]; this process is closely associated with the heme metabolism pathway. This evidence concerns the gene CASP3 and osteoporosis.